Alliance for Patient Access

Telehealth: The Balanced Approach

Rare Disease Advisory Councils

What is RSV?

Medication Use in Long-Term Care Facilities

Biologics and Biosimilars: Increasing Treatment Options

Telehealth: The Balanced Approach

Melanies RSV Story

What to Expect From Asthma Care

Challenges in Rare Disease Treatment

Barriers to Patient Access: Prior Authorization

The Dangers of RSV

The Gap Baby: An RSV Story

Understanding Patient-Centered Care

Why FDA Fast Tracking Matters to Cystic Fibrosis Patients

Clinical Pathways: When Personalized Health Care Goes Off Course

Understanding Value-Based Contracting

Gout & Uric Acid

A Roadmap to Better Gout Care

Why Bad Drug Ads are Bad for Patients

Understanding COVID-19 Vaccines

The Thyroid Eye Disease Experience: Signs and Symptoms

Alternative Funding Programs

Thyroid Eye Disease Patient & Caregiver Event

Bad Drug Ads Have Real-Life Consequences

Spotlight on Patient Access

Emilys RSV Story

The Thyroid Eye Disease Experience

Understanding Prior Authorization

The Umbrella of Immunizations

Dismantling Access Barriers to Obesity Treatments

Making Migraine Treatment Accessible

Caring for Patients with Hypertrophic Cardiomyopathy

The Diagnostic Odyssey

The Thyroid Eye Disease Experience: Mental Health

GAfPA Roundtable on the State of Clinical Trials in Brazil

Medicare and Obesity Treatment

Taking Serious Mental Illness Seriously

The Generic Drug Approval Process

Prescription Drug Affordability Boards & Patient Access

Medicare Administrative Contractors

Living Well With Thyroid Eye Disease

[Webinar] Survey Briefing: The Indirect Impact of RSV

Emerging Trends: What Employers Need to Know About Alternative Funding Programs & Drug Carveouts

Virtual Thyroid Eye Disease Patient & Caregiver Event: Presented in Russian

The Obesity & Mental Health Connection

Managing RSV’s Indirect Impact

Closing the Gap: Disparities & RSV

The Co-Pay Surprise